Stoke Therapeutics, Inc.
USD32.39
+0.39 (+1.22%)
CEO
Ian F. Smith
IPO Date
2019-06-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$32.63
Prev. Close
$32.00
Day Low
$31.63
Day High
$32.77
52W Low
$11.19
52W High
$40.22
Market Cap
$2.02B
Volume
0.64M
| 17,786 |
| $29.46 |
| 5 Jun 2026 | Smith Julie | director | A-Award | Acquired | 17,786 | $29.46 |
| 5 Jun 2026 | LEVIN ARTHUR A | director | A-Award | Acquired | 17,786 | $29.46 |
| 5 Jun 2026 | Krainer Adrian R. | director | A-Award | Acquired | 17,786 | $29.46 |
| 5 Jun 2026 | Kaye Edward M. MD | director | A-Award | Acquired | 17,786 | $29.46 |
| 5 Jun 2026 | Harrison Seth Loring | director | A-Award | Acquired | 17,786 | $29.46 |
| 5 Jun 2026 | Burstein Jennifer | director | A-Award | Acquired | 17,786 | $29.46 |
| 3 Jun 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | S-Sale | Disposed | 1,795 | $30.58 |
| 5 May 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | S-Sale | Disposed | 2,243 | $32.79 |